Skip to main content
. 2011 Dec 13;16(12):10324–10336. doi: 10.3390/molecules161210324

Table 1.

Groups of mice with different treatments in vivo experiments.

Groups NSS (mLkg−1d−1) Cy (mgkg−1d−1) NSS (mLkg−1d−1) LP3 (mgkg−1d−1) Ganoderan (mgkg−1d−1)
Intraperitoneal injection (days 1–3) Peroral administration (days 4–18)
Normal control 5 5
Model control 80 5
LP(I) 80 50
LP(II) 80 100
LP(III) 80 200
Ganoderan 80 50

NSS: normal sodium solution; Cy: cyclophosphamide; LP3: longan pulp polysaccharide-protein complex 3.